BioSeed is a fast-paced, one-day pitching event, owned and organized by OBN. It is specifically designed for innovative, early-stage life sciences R&D companies seeking seed funding to showcase their ventures and meet with an extensive audience of active life sciences investors.

Since its first event in 2017, BioSeed has demonstrated significant impact and scale. It has welcomed approximately 630 seed-stage companies across a broad range of therapeutic and technological areas. These presenters have connected with a combined audience of over 1500 active life sciences investors, including VCs, Big Pharma, private equity firms, banks, angels, and family offices.

The event structure is designed for efficiency and support. It features up to 50 x 5-minute company presentations from early-stage life sciences R&D companies, with all presenters benefiting from mandatory pitch training and a deck review service. Crucially, the event facilitates private, pre-scheduled partnering meetings, held both in-person (on January 19th) and virtually (on January 20th), powered by partneringONE. Attendees also benefit from networking opportunities throughout the day, along with access to a post-event drinks reception.

Attendance at BioSeed is kept exclusive, ensuring high-quality engagement. It is reserved for early-stage R&D companies and Technology Transfer teams from academic institutions that are actively seeking seed funding. The audience also includes life sciences Investors looking for new funding opportunities, alongside a limited number of corporate and industry sponsors.